| Record ID | marc_columbia/Columbia-extract-20221130-011.mrc:316771421:4631 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-011.mrc:316771421:4631?format=raw |
LEADER: 04631cam a2200325 a 4500
001 5498213
005 20221110045953.0
008 051219s2006 flua bf 001 0 eng
010 $a 2005043716
020 $a1574446649 (acid-free paper)
035 $a(OCoLC)58545988
035 $a(OCoLC)ocm58545988
035 $a(DLC) 2005043716
035 $a(NNC)5498213
035 $a5498213
040 $aDLC$cDLC$dDLC$dOrLoB-B
050 00 $aTP201$b.H26 2006
082 00 $a661/.8$222
245 00 $aHandbook of chiral chemicals /$cedited by David Ager.
250 $a2nd ed.
260 $aBoca Raton :$bTaylor & Francis,$c2006.
300 $a648 pages :$billustrations ;$c27 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tIntroduction /$rDavid J. Ager -- $gCh. 2.$tAmino acids /$rDavid J. Ager -- $gCh. 3.$tMicrobial pathway engineering for amino acid manufacture /$rIan Fotheringham and Paul P. Taylor -- $gCh. 4.$tCarbohydrates in synthesis /$rDavid J. Ager -- $gCh. 5.$tTerpenes : the expansion of the chiral pool /$rWeiguo Liu -- $gCh. 6.$tResolutions at large scale : case studies /$rWeiguo Liu -- $gCh. 7.$tNew developments in crystallization-induced resolution /$rBernard Kaptein, Ton R. Vries, Jose W. Nieuwenhuijzen, Richard M. Kellogg, Reinier F. P. Grimbergen and Quirinus B. Broxterman -- $gCh. 8.$tThe role of cis-1-amino-2-indanol in resolution processes /$rChris H. Senanayake, Dhileepkumar Krishnamurthy and Isabelle Gallou -- $gCh. 9.$tAsymmetric oxidations /$rDavid J. Ager and David R. Allen -- $gCh. 10.$tAsymmetric epoxidation of olefins by chiral ketones /$rYian Shi -- $gCh. 11.$tOzonolysis in the production of chiral fine chemicals /$rJanine McGuire, Gary Bond and Peter J. Haslam -- $gCh. 12.$tTransition metal catalyzed hydrogenations, isomerizations, and other reactions /$rScott A. Laneman -- $gCh. 13.$tModular, chiral P-heterocycles in asymmetric catalysis /$rMark J. Burk and James A. Ramsden -- $gCh. 14.$tAsymmetric olefin hydrogenation using monodentate BINOL- and bisphenol-based ligands : phosphonites, phosphites, and phosphoramidites /$rJohannes G. de Vries -- $gCh. 15.$tAsymmetric catalytic hydrogenation reactions with ferrocene-based diphosphine ligands /$rHans-Ulrich Blaser, Matthias Lotz and Felix Spindler -- $gCh. 16.$tAsymmetric reduction of prochiral ketones catalyzed by oxazaborolidines /$rMichel Bulliard -- $gCh. 17.$tcis-1-amino-2-indanol-derived ligands in asymmetric catalysis /$rChris H. Senanayake, Dhileepkumar Krishnamurthy and Isabelle Gallou -- $gCh. 18.$tEnantioselective hydrogenation of activated ketones using heterogeneous Pt catalysts modified with cinchona alkaloids /$rMartin Studer and Hans-Ulrich Blaser -- $gCh. 19.$tBiotransformations : "green" processes for the synthesis of chiral fine chemicals /$rDavid P. Pantaleone -- $gCh. 20.$tCombining enzyme discovery and evolution to develop biocatalysts /$rMark Burk, Nelson Barton, Grace DeSantis, William Greenberg, David Weiner and Lishan Zhao -- $gCh. 21.$tOne-pot synthesis and the integration of chemical and biocatalytic conversions /$rPaul A. Dalby, Gary J. Lye and John M. Woodley -- $gCh. 22.$tSubstitution reactions /$rDavid J. Ager -- $gCh. 23.$tIndustrial applications of chiral auxiliaries /$rDavid R. Schaad -- $gCh. 24.$tThe role and importance of cis-1-amino-2-indanol in biological systems and asymmetric processes /$rChris H. Senanayake, Dhileepkumar Krishnamurthy and Isabelle Gallou -- $gCh. 25.$tEnantiopure amines by chirality transfer using (R)-phenylglycine amide /$rBen de Lange, Wilhelmus H. J. Boesten, Marcel van der Sluis, Patrick G. H. Uiterweerd, Henk L. M. Elsenberg, Richard M. Kellogg and Quirinus B. Broxterman -- $gCh. 26.$tPericyclic reactions /$rMichael B. East -- $gCh. 27.$tAsymmetric free-radical reductions mediated by chiral stannanes, germanes, and silanes /$rJens Beckmann, Dainis Dakternieks and Carl H. Schiesser -- $gCh. 28.$tMetathesis reactions /$rDavid R. Allen -- $gCh. 29.$tSynthesis of homochiral compounds : a small company's role /$rKaren Etherington, Ed Irving, Feodor Scheinmann and Basil Wakefield -- $gCh. 30.$tCommercial synthesis of the antiglaucoma prostanoid travoprost /$rMartin Fox, Mark Jackson, Ian C. Lennon and Raymond McCague -- $gCh. 31.$tSynthesis of large volume products /$rDavid J. Ager and Colin R. Bayley.
650 0 $aChemicals$vHandbooks, manuals, etc.
650 0 $aEnantiomers$vHandbooks, manuals, etc.
700 1 $aAger, David J.$0http://id.loc.gov/authorities/names/n93085320
852 00 $boff,che$hTP201$i.H26 2006